E-cadherin immunohistochemistry in breast pathology: uses and pitfalls
- PMID: 26768029
- DOI: 10.1111/his.12869
E-cadherin immunohistochemistry in breast pathology: uses and pitfalls
Abstract
E-cadherin immunohistochemistry is used commonly in surgical pathology practice to help distinguish lobular carcinoma in situ from ductal carcinoma in situ and invasive lobular carcinoma from invasive ductal carcinoma in histologically problematic or indeterminate cases. However, the interpretation of E-cadherin immunostains is not always straightforward. Failure to recognize the pitfalls and limitations of E-cadherin immunostains can lead to an erroneous diagnosis which may result in inappropriate patient management, particularly for patients with in-situ lesions. In this paper we review the uses and, particularly, the pitfalls in the interpretation of E-cadherin immunostains in distinguishing lobular from ductal lesions of the breast.
Keywords: E-cadherin; breast; lobular carcinoma.
© 2015 John Wiley & Sons Ltd.
Similar articles
-
Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.Am J Clin Pathol. 2001 Jan;115(1):85-98. doi: 10.1309/FDHX-L92R-BATQ-2GE0. Am J Clin Pathol. 2001. PMID: 11190811
-
Use of immunohistochemistry in the diagnosis of problematic breast lesions.J Clin Pathol. 2013 Jun;66(6):471-7. doi: 10.1136/jclinpath-2012-201109. Epub 2013 Mar 13. J Clin Pathol. 2013. PMID: 23486609 Review.
-
Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin.Am J Surg Pathol. 2007 Mar;31(3):427-37. doi: 10.1097/01.pas.0000213386.63160.3f. Am J Surg Pathol. 2007. PMID: 17325485
-
E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions.Am J Clin Pathol. 2001 Apr;115(4):534-42. doi: 10.1309/B0DD-4M7H-GJG1-7KCW. Am J Clin Pathol. 2001. PMID: 11293901
-
Differential diagnosis of solid carcinoma in situ.Semin Diagn Pathol. 2004 Feb;21(1):25-31. doi: 10.1053/j.semdp.2003.10.009. Semin Diagn Pathol. 2004. PMID: 15074556 Review.
Cited by
-
Implementing an On-Slide Molecular Classification of Gastric Cancer: A Tissue Microarray Study.Cancers (Basel). 2023 Dec 21;16(1):55. doi: 10.3390/cancers16010055. Cancers (Basel). 2023. PMID: 38201483 Free PMC article.
-
Insights into E-Cadherin Impairment in CDH1-Unaltered Invasive Lobular Carcinoma: A Comprehensive Bioinformatic Study.Int J Mol Sci. 2024 Aug 17;25(16):8961. doi: 10.3390/ijms25168961. Int J Mol Sci. 2024. PMID: 39201647 Free PMC article.
-
American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications.Ann Diagn Pathol. 2020 Apr;45:151481. doi: 10.1016/j.anndiagpath.2020.151481. Epub 2020 Feb 15. Ann Diagn Pathol. 2020. PMID: 32120324 Free PMC article. Review.
-
Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations.Mod Pathol. 2021 Jul;34(7):1282-1296. doi: 10.1038/s41379-021-00742-9. Epub 2021 Mar 22. Mod Pathol. 2021. PMID: 33753865 Free PMC article.
-
Lobular Breast Cancer: Histomorphology and Different Concepts of a Special Spectrum of Tumors.Cancers (Basel). 2021 Jul 22;13(15):3695. doi: 10.3390/cancers13153695. Cancers (Basel). 2021. PMID: 34359596 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical